Research for Alzheimer's and Regenerative Medicine now Benefitting from Nanotronics' Microscopy--
New York (MMD Newswire) January 30, 2012 -- Nanotronics Imaging, a pioneer in nano-inspection for semiconductors, announced today that it will assist medical research by applying its groundbreaking inspection methods to neuroscience, regenerative medicine and other life science fields. Its inaugural partners are the Joseph L. Mailman School of Public Health at Columbia University Medical Center, and the McGowen Institute at University of Pittsburgh. Both institutions have begun to make promising strides with Nanotronics' systems in Alzheimer's research and large-scale regenerative medicine.
"One of the major challenges for scientific research is to have the ability to rapidly screen materials at the nanoscale, and in no field is that more critical than life-saving medical research," said Nanotronics Imaging CEO and founder Dr. Matthew Putman. "Scientists recently discovered, for example, that Alzheimer's disease is not irreversible. Rapid high-resolution imaging of the brain's neurons will be critical to furthering such medical advances, as well as in the study of other debilitating diseases such as schizophrenia. Our high resolution nSPEC® microscope has unparalleled high-area capabilities, covering large areas of the brain, and can reduce imaging time from weeks down to days or even minutes."